Overview

Trial to Compare the Effects of Tibolone (Livial®) and Continuous Combined Low-Dose Estradiol/Noresterone (Activelle®)

Status:
Completed
Trial end date:
2005-03-01
Target enrollment:
Participant gender:
Summary
The present trial is undertaken to compare the effects of Tibolone with a low-dose HRT regimen.
Phase:
Phase 4
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Estradiol
Estradiol 17 beta-cypionate
Estradiol 3-benzoate
Estradiol valerate
Polyestradiol phosphate
Tibolone